ICB binding with SK1‐targeted inhibitors can significantly increase CD8+T/Treg ratio, supporting the important role of tumor SK1 in immune escape..Therefore, inhibition of SK1 may be an important strategy to enhance ICB response. Here, CD8A is linked to neoplasm.